Trials / Terminated
TerminatedNCT02005133
A Prospective, Observational, Multicentre, 2 Year Study Evaluating the Use of Eylea (Aflibercept) for the Treatment of Neovascular (Wet) Age-related Macular Degeneration in UK NHS Opthalmology Clinics
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 188 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
To assess the use of aflibercept over a 2 year period in VEGF inhibitor naive and prior treated wet AMD patients managed in 'real wold' clinic settings.
Conditions
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2015-10-01
- Completion
- 2015-10-01
- First posted
- 2013-12-09
- Last updated
- 2017-02-28
Locations
17 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02005133. Inclusion in this directory is not an endorsement.